secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2023-07-05T23:59:59+00:00
Accession:  0001193125-23-181966
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos Therapeutics transfers to Nasdaq Capital Market; gets 180-day bid price extension to Jan 2, 2024
--------------------------------------------------------------------------------

- Transfer of Common Stock listing from Nasdaq Global Select to Capital Market approved July 5, effective July 7, 2023.
- Company granted additional 180 calendar days until January 2, 2024 to regain $1.00 minimum bid price compliance.
- Alaunos intends to consider a reverse stock split if necessary to cure the bid price deficiency.
- No assurance the company will regain compliance or meet other Nasdaq listing criteria.
- Common stock continues to trade under symbol TCRT on the Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000119312523181966/0001193125-23-181966-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000119312523181966/d526439d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-181966

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer